Risk Factors in Serrated Pathway Lesions: N-Glycosylation Profile as a Potential Biomarker of Progression to Malignancy
Introduction: The serrated pathway contributes to interval colorectal cancers, highlighting the need for new biomarkers to assess lesion progression risk. The β1,6-GlcNAc branched N-glycans expression in CRC cells was associated with an invasive phenotype and with immune evasion. Therefore, this stu...
Main Authors: | Henrique Fernandes-Mendes, Catarina M. Azevedo, Mónica Garrido, Carolina Lemos, Isabel Pedroto, Salomé S. Pinho, Ricardo Marcos-Pinto, Ângela Fernandes |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2024-01-01
|
Series: | GE: Portuguese Journal of Gastroenterology |
Subjects: | |
Online Access: | https://beta.karger.com/Article/FullText/535920 |
Similar Items
-
The Molecular Hallmarks of the Serrated Pathway in Colorectal Cancer
by: Fatima Domenica Elisa De Palma, et al.
Published: (2019-07-01) -
Serrated Colorectal Lesions: An Up-to-Date Review from Histological Pattern to Molecular Pathogenesis
by: Martino Mezzapesa, et al.
Published: (2022-04-01) -
Aberrant PRDM2 methylation as an early event in serrated lesions destined to evolve into microsatellite‐instable colorectal cancers
by: David EFWM vanToledo, et al.
Published: (2024-03-01) -
Downregulation of SMOC1 is associated with progression of colorectal traditional serrated adenomas
by: Hironori Aoki, et al.
Published: (2024-03-01) -
Significance of Micromorphological Characteristics and Expression of Intermediate Filament Proteins CK7 and CK20 in the Differential Diagnosis of Serrated Lesions of the Colorectum
by: Ivan Ilić, et al.
Published: (2023-02-01)